{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:51:02Z","timestamp":1785865862886,"version":"3.56.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:p>\n                    To explore the relationship between microRNAs (miRNAs) in T lymphocytes and primary hypertension in Kazakh people. Five Kazakh patients with primary hypertension who were initially diagnosed and untreated, as well as 5 healthy individuals who underwent physical examinations during the same period, were selected. Plasma samples of the subjects were collected, and T lymphocytes were isolated. High throughput second-generation sequencing technology was used to detect changes in miRNA expression in the two groups of subjects, and differentially expressed miRNAs were screened for further analysis of lymphocytes IL-6, IL-17, and interferon-gamma (IFN-\u03b3), tumor necrosis factor-alpha (TNF-\u03b1) mRNA expression level detection; Serum IL-6, IL-17, IFN-\u03b3, TNF-\u03b1 detection of cytokine levels; Correlation analysis and clinical value prediction between differential expression of miRNAs and mean arterial pressure in patients. A total of 1754 miRNAs were detected in this study. Compared with the control group, 33 miRNAs were upregulated in the hypertension group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05), and 60 miRNAs were downregulated (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Verify 6 miRNAs in the sample population: miR-15b-5p, miR-374-5p, miR-138-5p, miR-320a-3p, miR-423-5p, and miR-92a-3p. The quantitative real-time polymerase chain reaction results showed that among the 6 differentially expressed miRNAs, miR-320a-3p, miR-423-5p, and miR-92a-3p were downregulated in the hypertensive group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Lymphocyte IFN in hypertensive group-\u03b3, The expression level of IL-17 mRNA increases, and IL-6 and IFN in plasma-\u03b3, The level of IL-17 has increased. The area under the miRNAs curve for differential expression of lymphocytes in Kazakh hypertensive patients, where miR-423-5p, area under the curve (AUC): 0.696 (95% confidence interval (CI): 0.533\u20130.859); MiR-320a-3p, AUC: 0.764 (95% CI: 0.609\u20130.919). The expression of miR-92a-3p, miR-423-5p, and miR-320a-3p in T lymphocytes of Kazakh hypertensive patients is downregulated, with good diagnostic reference value (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05).\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046063","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:01:17Z","timestamp":1764972077000},"page":"e46063","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between hypertensive patients of Kazakh nationality in Xinjiang and T lymphocytes microRNAs"],"prefix":"10.1097","volume":"104","author":[{"given":"Jian","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Chao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Xi\u2019an Daxing Hospital, Yan\u2019an University, Xi\u2019an, Shaanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Gao","sequence":"additional","affiliation":[{"name":"Heart Center, The 7\u2019th People\u2019s Hospital of Zhengzhou, Zhengzhou, Henan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8722-644X","authenticated-orcid":false,"given":"Yuanming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41577-019-0160-5","article-title":"Immune mechanisms of hypertension.","volume":"19","author":"Drummond","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/CIRCRESAHA.121.318052","article-title":"Hypertension: do inflammation and immunity hold the key to solving this epidemic?","volume":"128","author":"Madhur","year":"2021","journal-title":"Circ Res"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"1098725","DOI":"10.3389\/fimmu.2022.1098725","article-title":"Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets.","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/CIRCRESAHA.117.304611","article-title":"CD8+ T cells regulate monopoiesis and circulating Ly6C-high monocyte levels in atherosclerosis in mice.","volume":"117","author":"Cochain","year":"2015","journal-title":"Circ Res"},{"key":"R5-20260523","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cyto.b.10052","article-title":"Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.","volume":"56","author":"Gallego","year":"2003","journal-title":"Cytometry B Clin Cytom"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.4049\/jimmunol.165.6.2982","article-title":"Coordinate regulation of the IL-4, IL-13, and IL-5 cytokine cluster in Th2 clones revealed by allelic expression patterns.","volume":"165","author":"Kelly","year":"2000","journal-title":"J Immunol"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/art.27203","article-title":"Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.","volume":"62","author":"Ma","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.1200633","article-title":"Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity.","volume":"189","author":"Haque","year":"2012","journal-title":"J Immunol"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/jch.13704","article-title":"Down-regulation of miRNA 145 and up-regulation of miRNA 4516 may be associated with primary hypertension.","volume":"21","author":"Ozkan","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R10-20260523","first-page":"11761","article-title":"Correlation between serum microRNA-136 levels and RAAS biochemical markers in patients with essential hypertension.","volume":"24","author":"Chu","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature09783","article-title":"Pervasive roles of microRNAs in cardiovascular biology.","volume":"469","author":"Small","year":"2011","journal-title":"Nature"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.106.141986","article-title":"MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation.","volume":"100","author":"Ji","year":"2007","journal-title":"Circ Res"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2174\/138945010791591377","article-title":"MicroRNAs in arterial remodelling, inflammation and atherosclerosis.","volume":"11","author":"Weber","year":"2010","journal-title":"Curr Drug Targets"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options.","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1007\/s00018-021-03979-4","article-title":"MicroRNA-34a: the bad guy in age-related vascular diseases.","volume":"78","author":"Raucci","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"R16-20260523","first-page":"5497","article-title":"Molecular mechanisms in vascular injury induced by hypertension: expression and role of microRNA-34a.","volume":"14","author":"Liu","year":"2017","journal-title":"Exp Ther Med"},{"key":"R17-20260523","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/HYPERTENSIONAHA.114.03863","article-title":"Tumor necrosis factor-alpha produced in the kidney contributes to angiotensin II-dependent hypertension.","volume":"64","author":"Zhang","year":"2014","journal-title":"Hypertension"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.112.199265","article-title":"Interferon-gamma signaling inhibition ameliorates angiotensin II-induced cardiac damage.","volume":"60","author":"Marko","year":"2012","journal-title":"Hypertension"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/HYPERTENSIONAHA.109.137158","article-title":"Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction.","volume":"54","author":"Didion","year":"2009","journal-title":"Hypertension"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction.","volume":"204","author":"Guzik","year":"2007","journal-title":"J Exp Med"},{"key":"R21-20260523","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/cvr\/cvx108","article-title":"The role of infiltrating immune cells in dysfunctional adipose tissue.","volume":"113","author":"Guzik","year":"2017","journal-title":"Cardiovasc Res"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.113.02883","article-title":"Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes.","volume":"63","author":"Amador","year":"2014","journal-title":"Hypertension"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/cvr\/cvs422","article-title":"Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension.","volume":"97","author":"Nguyen","year":"2013","journal-title":"Cardiovasc Res"},{"key":"R24-20260523","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000248135.97380.76","article-title":"Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.","volume":"48","author":"Luther","year":"2006","journal-title":"Hypertension"},{"key":"R25-20260523","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"R26-20260523","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/jch.12612","article-title":"Elevated serum level of interleukin 17 in a population with prehypertension.","volume":"17","author":"Yao","year":"2015","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R27-20260523","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2369-15-159","article-title":"The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients.","volume":"15","author":"Ates","year":"2014","journal-title":"BMC Nephrol"},{"key":"R28-20260523","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13075-016-1101-3","article-title":"Rituximab induces phenotypical and functional changes of NK cells in a non-malignant experimental setting.","volume":"18","author":"Merkt","year":"2016","journal-title":"Arthritis Res Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:49:05Z","timestamp":1785862145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":28,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046063","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2024-11-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}